W
Werewolf Therapeutics, Inc. (HOWL)
NMS – Real Time Price. Currency in USD
0.32
-0.01 (-3.29%)
At close: Jun 26, 2026, 4:00 PM EDT
0.33
+0.01 (2.14%)
After-hours: Jun 26, 2026, 7:29 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
0.32
-0.01 (-3.29%)
At close: Jun 26, 2026, 4:00 PM EDT
0.33
+0.01 (2.14%)
After-hours: Jun 26, 2026, 7:29 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $46.5M significantly exceed its total debt $37.7M, ensuring strong financial flexibility
Total current assets $48.7M exceed Total current liabilities $38.5M, highlighting excellent liquidity
Debt-to-equity ratio (3.1) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-6.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$10.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.27 | 6.05 | 7.0 | |
| Quick ratio | 1.27 | 5.63 | 7.0 | |
| Debt to Equity | 3.09 | 0.30 | 2.0 | |
| Debt to Assets | 0.65 | 1.04 | 3.0 | |
| Interest coverage | -6.55 | -16.91 | 1.0 | |
| Weighted average score | 4.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 16M | 20M | 2M | N/A | N/A |
| Gross Profit | 14M | 18M | 71K | -2M | -2M |
| Operating Income | -56M | -41M | -74M | -61M | -52M |
| Net Income | -54M | -37M | -71M | -61M | -56M |
| EBITDA | -54M | -39M | -72M | -59M | -50M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 30 | 5.5 |
| Next quarter | N/A | 38.89 | 5.5 |
| Current year | N/A | 33.08 | 5.5 |
| Next year | N/A | -79.21 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -61.45 | -39.99 | 3.87 | 4.0 |
| Y/Y | 999 | 25.19 | 30 | 44.07 | 10 |
| 3y average | -56.3 | -14.78 | 2.24 | -17.07 | 1.5 |
| 5y average | 365.81 | -56.86 | -37.36 | -35.88 | 3.3 |
| Weighted average score | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |